Design and Biodistribution of ۹۹mTc-Labeled Gold/Gold Sulfide Nanoconjugates: A Preclinical Evaluation in Balb/c Mice

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 58

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJMP-22-4_003

تاریخ نمایه سازی: 12 آذر 1404

چکیده مقاله:

Introduction: Gold/gold sulfide (GGS) nanoparticles exhibit strong near-infrared (NIR) absorption, high chemical stability, low cytotoxicity, and ease of surface functionalization, enabling deep tissue penetration and targeted cancer theranostics. This study aimed to develop and evaluate ۹۹mTc-labeled PEGylated GGS nanoconjugates for potential SPECT imaging applications.Material and Methods: GGS nanoparticles were synthesized by reacting HAuCl۴ with Na₂S and stabilized with polyvinylpyrrolidone (PVP). PEGylated GGS nanoparticles were radiolabeled with ۹۹mTc using SnCl۲, and radiochemical purity and stability were assessed via ITLC in RPMI and human serum up to ۲۴ h. Cytotoxicity and cellular uptake were evaluated in CT۲۶ colon carcinoma cells. Biodistribution was studied in BALB/c mice at ۱, ۴, and ۲۴h post-intravenous injection by gamma counting of excised organs.Results: ۹۹mTc-GGS-PVP nanoconjugates had an average diameter of ~۶۵.۹ nm, maintained strong NIR absorption post-labeling, and achieved high radiochemical purity (۹۷.۱ ± ۱.۱%) with stability >۸۵% in RPMI and >۸۲% in human serum at ۲۴h. Cytotoxicity was minimal, with ۷۸% cell viability at ۱۲۵ GGS. Cellular uptake increased from ۱.۹۸% at ۲h to ۱۰.۰% at ۲۴h. In vivo, the liver showed the highest uptake (۵۱.۴۴ ± ۷.۵۴ %ID/g at ۱h), decreasing to ۱۴.۱۹ ± ۶.۵۴ %ID/g at ۲۴h; spleen uptake was markedly lower (۱.۵۱ ± ۰.۸۱ %ID/g at ۱h, ۰.۷۶۵ ± ۰.۲۸ %ID/g at ۲۴h).Conclusion: The synthesized ۹۹mTc-GGS-PVP nanoparticles demonstrated high stability, low toxicity, favorable biodistribution, and preserved NIR absorption properties, making them promising candidates for dual-modality cancer theranostics. Their radiolabeling efficiency and biodistribution support their use as radiotracers for SPECT imaging and potential integration into combined diagnostic and therapeutic (theranostic) platforms.

نویسندگان

Esmat Ramezanzadeh

Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Medical Physics Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Ameneh Sazgarnia

Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Medical Physics Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Hossein Bahreyni Toosi

Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran Medical Physics Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Kayvan Sadri

Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Day ES, Bickford LR, Slater JH, Riggall NS, Drezek RA, ...
  • Gobin AM, Watkins EM, Quevedo E, Colvin VL, West JL. ...
  • Ramezanzadeh E, Sadri K, Momennezhad M, Dolat E, Sazgarnia A. ...
  • Sadat-Darbandi M, Fathabadi A, Oloomi S, Sazgarnia A. Dual-Modality Therapy: ...
  • Vines JB, Yoon J-H, Ryu N-E, Lim D-J, Park H. ...
  • Li R, Tu W, Wang H, Dai Z. Near-infrared light ...
  • Rahaman M, Moras S, He L, Madeira TI, Zahn DR. ...
  • Demir M, Çizmeciyan MN, Sipahioğlu D, Khoshzaban A, Ünlü MB, ...
  • Sadat-Darbandi M, Fathabadi A, Oloomi S, Sazgarnia A. Dual-Modality Therapy: ...
  • Nejabat M, Samie A, Ramezani M, Alibolandi M, Abnous K, ...
  • Wang Y, Gao Z, Han Z, Liu Y, Yang H, ...
  • Gao W, Fan X, Bi Y, Zhou Z, Yuan Y. ...
  • Murphy CJ, Chang H-H, Falagan-Lotsch P, Gole MT, Hofmann DM, ...
  • Mochizuki C, Nakamura J, Nakamura M. Development of non-porous silica ...
  • Sun X, Zhang G, Patel D, Stephens D, Gobin AM. ...
  • Liu Y, Chorniak E, Odion R, Etienne W, Nair SK, ...
  • Guo Z, Zhu AT, Fang RH, Zhang L. Recent Developments ...
  • Arulsudar N, Subramanian N, Mishra P, Sharma R, Murthy R. ...
  • Banihashem S, Nikpour Nezhati M, Panahi HA, Shakeri-Zadeh A. Synthesis ...
  • Eshghi H, Attaran N, Sazgarnia A, Mirzaie N, Shanei A. ...
  • Evaluating Estimated Dose outside the Patients Undergoing Myocardial Perfusion Imaging with ۹۹mTc-MIBI [مقاله ژورنالی]
  • Kamiloglu S, Sari G, Ozdal T, Capanoglu E. Guidelines for ...
  • Kozics K, Sramkova M, Kopecka K, Begerova P, Manova A, ...
  • Abu-Dief AM, Alsehli M, Awaad A. A higher dose of ...
  • Gold-gold sulfide nanoshell as a novel intensifier for anti-tumor effects of radiofrequency fields [مقاله ژورنالی]
  • Sadeghi HR, Toosi MHB, Soudmand S, Sadoughi HR, Sazgarnia A. ...
  • Xu L, Xu M, Sun X, Feliu N, Feng L, ...
  • Gawali P, Saraswat A, Bhide S, Gupta S, Patel K. ...
  • Shinde VR, Revi N, Murugappan S, Singh SP, Rengan AK. ...
  • Kobayashi H, Watanabe R, Choyke PL. Improving conventional enhanced permeability ...
  • Patil T, Gambhir R, Vibhute A, Tiwari AP. Gold nanoparticles: ...
  • Cheng T-M, Chu H-Y, Huang H-M, Li Z-L, Chen C-Y, ...
  • Haripriyaa M, Suthindhiran K. Pharmacokinetics of nanoparticles: current knowledge, future ...
  • Zhang W, Taheri-Ledari R, Ganjali F, Mirmohammadi SS, Qazi FS, ...
  • Varma S, Dey S, Palanisamy D. Cellular uptake pathways of ...
  • Cong VT, Houng JL, Kavallaris M, Chen X, Tilley RD, ...
  • نمایش کامل مراجع